Lamivudine 00904-6583
Product NDC
00904-6583- Manufacturer
- Major Pharmaceuticals
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 2, 2011
- Listing Expires
- December 31, 2027
- Application
- ANDA091606
Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 150 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(1)
30 BLISTER PACK in 1 CARTON (0904-6583-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK